REGN Regeneron Pharmaceuticals, Inc.

$781.49▼ -1.48% Healthcare Other
After hours $784.14▲ +0.34% Sep 11, 7:36 PM ET
Volume 443.9K Avg Volume (10D) 634.3K
Key Metrics & Fundamentals
Market Cap
$80.46B
P/E Ratio
19.3
Div Yield
0.47%
52W Range
541.00 - 859.34
% vs 50 MA
4.00%
% vs 200 MA
6.54%
RSI-14
45.7
MACD Histogram
-9.1500
Beta (1Y vs SPY)
0.48
Free Cash Flow
$521.80M
Gross Rev
$4.29B
Gross Profit
$3.71B
EBITDA
$1.73B
COGS
$576.50M
Operating Exp
$2.29B
Operating Income
$1.42B
EBIT
$1.42B
Pretax Income
$1.53B
Net Income
$1.30B
EPS (Diluted)
12.23
Price & Volume History
Loading chart…
Recent News
Regeneron Eyes 2026 Catalysts as EYLEA HD and DUPIXENT Drive Growth
MarketBeat · Sep 12, 2026 7:02 AM
Regeneron Pharmaceuticals More Likely to Retain Eylea HD Patent, RBC Says
MT Newswires · Sep 10, 2026 3:57 PM
Here’s Why The Fund Sold Regeneron Pharmaceuticals (REGN)
Insider Monkey · Sep 9, 2026 2:51 PM
FDA Accepts & Gives Priority Review to Intellia's BLA for HAE Drug
Zacks · Sep 9, 2026 2:05 PM
BMO Capital Adjusts Price Target on Regeneron Pharmaceuticals to $920 From $800, Keeps Outperform Rating
MT Newswires · Sep 9, 2026 12:37 PM
Evaluating Bullish Potential in Regeneron Pharmaceuticals (REGN) Stock
Insider Monkey · Sep 8, 2026 3:41 PM
Big Short Billionaire Goes Long: Michael Burry Avoids AI, Bets on Beaten own Stocks Instead
24/7 Wall St. · Sep 8, 2026 2:05 PM
3 Reasons to Avoid REGN and 1 Stock to Buy Instead
StockStory · Sep 8, 2026 1:51 PM
IBB Just Beat the S&P 500 by 22 Points in Three Months. Are You Late to the Party?
24/7 Wall St. · Sep 7, 2026 4:22 PM
Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now?
Motley Fool · Sep 4, 2026 6:50 PM
Financial Overview - Income Statement Quarterly

See REGN's money flow as a full page

Social Sentiment
Avg +0.64 · 13 posts
PriceTargetDiscussionHere's 5 value plays trading at multi-year PE lows
r/StockMarket · Sep 4, 2025
REGN is analyzed as a value play with a lower P/B ratio and growth potential.
positive +0.60
DDNewsDiscussionMy 3 Undervalued Companies Finds Of The Week
r/StockMarket · Aug 29, 2025
The post describes Regeneron's financials as ‘almost too good’ and presents a positive outlook.
positive +0.70
DiscussionTradeThoughts on holding onto a stock too long
r/investing · Aug 9, 2025
The post expresses regret about holding REGN and its subsequent decline, indicating a negative sentiment.
negative +0.60
DiscussionTradeMeme$REGN - it's like umbrella corporation from Resident Evil and it's on sale
r/wallstreetbets · Jul 22, 2025
The post expresses a bullish view on REGN, highlighting sales, market cap, and potential upside.
positive +0.60
NewsDiscussionMeme$REGN - it's like umbrella corporation from Resident Evil and it's on sale
r/wallstreetbets · Jul 22, 2025
The post frames the stock as 'on sale' and highlights potential upside with the glp1 drug, despite recent failures. Sentiment is bullish.
positive +0.70
Page 1 of 3 (13 total)
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙